Skip to content
Screener

Medifast MED Q4 2025 Annual earnings

Reported February 17, 2026 · After market close

Revenue$75.1MBeat by $3.7M
EPS-$0.55Beat by $0.21
Revenue estimate$71.4M
EPS estimate-$0.76

Next report

Nov 9, 2026 (in 2 months)
Revenue estimate$71.3M
EPS estimate-$0.35

Financials

Q4 2025

Income statement

See full
Revenue$75.1M-36.9%
Gross profit$52.1M-40.9%
Operating income-$7.8M-1,201%
Net income-$18.1M-2,362%
EPS (diluted)-$1.65-2,457%

Balance sheet

See full
Cash & equivalents$89.3M-1.8%
Total debt$10.7M-33.7%
Total equity$198.9M-5.3%
Total assets$248.0M-12.8%

Cash flow

See full
CapEx$1.4M-40.9%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$117.39M-39.1%
Enterprise value$38.78M-67.1%
P/S0.3×0.0×

Profitability

See full
Gross margin71.3%-2.5pp
Operating margin-3.7%-4.2pp
Net margin-4.8%-5.2pp

Returns & leverage

See full
Return on equity-9.1%-10.1pp
Debt / equity0.1×0.0×
Current ratio4.7×+1.4×

Segments

By segment

See full
Optavia Segment$75.1M-36.9%

FAQ

When did Medifast report Q4 2025 earnings?
Medifast (MED) reported Q4 2025 earnings on February 17, 2026 after market close.
What were Medifast's Q4 2025 revenue and EPS?
Medifast reported revenue of $75.1M and eps of $-0.55 for Q4 2025.
Did Medifast beat estimates in Q4 2025?
Revenue beat the consensus estimate of $71.4M by $3.7M. EPS beat the consensus estimate of $-0.76 by $0.21.
How did Medifast's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 36.9% from $119.0M a year earlier.
Where can I find Medifast's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001628280-26-008641) and the 10-K periodic report (0001628280-26-008656) directly on SEC EDGAR. The filing index links above go to sec.gov.